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E
very now and then something happens 
which induces one to say, “See! I told 
you so.” Amusingly, the same event can 
induce diametrically opposed responses 
but of equal intensity. Let us construct a math-
ematical model of this situation. One’s emo-
tional response is oft en directly proportional to 
the intensity of a certain event: someone says 
something sarcastic about your work to a few 
others, and you raise an eyebrow; he says it to a 
large audience, and your anger is, say, fi ve times 
more. But there are certain types of events to 
which the intensity of the response varies expo-
nentially with that of the inciting event, except 
(please pay attention here) that the ‘sign’ diff ers 
depending on the personality or the political 
or cultural beliefs of the respondent. Th e rise 
and fall of Dr. Hwang Woo Suk seems to have 
produced such exponential responses. Sean 
Tipton, president-elect of the Coalition for the 
Advancement of Medical Research (a group that 
aims to promote stem-cell research), said, “Prob-
ably the strongest research oversight system in 
the world is at the National Institutes of Health, 
but they are pretty much on the sidelines” as a 
result of restrictions imposed by US President 
George Bush in 2001. “If you don’t allow the best 
American scientists to do the best — and best 
overseen — research, you force it overseas and 
into the private sector, and this is the result.”1 
On the other hand, Richard Doerfl inger, deputy 
director of the Secretariat for Pro-Life Activi-
ties at the United States Conference of Catholic 
Bishops, said, “It’s all very well to say one scandal 
shouldn’t set back the fi eld, but Hwang’s team 
was the fi eld… If his results are false, then aft er 
seven years of attempts worldwide, no one has 
succeeded in getting even the fi rst step in ‘thera-
peutic cloning’ to work on a practical scale. At 
what point do legislators stop throwing away 
good money aft er bad?”1 Yet another commen-
tator, David Dobbs, proclaimed in the New York 
Times, apparently starting from fi rst principles, 
“John Ioannidis…recently concluded that most 
articles published by biomedical journals are 
fl at-out wrong,”2 referring to an epidemiologist 
who studies the scientifi c literature.3 Left  in the 
middle were the editor of Science and various 
other scientists who, while embarrassed, seemed 
to say — sotto voce, of course — “Hey, wait a 
minute! It is disturbing when a colleague turns 
out to be a crook, but crooks exist in science 
as in any other activity, so let’s not infl ate the 
importance of this problem.”
What actually happened? Dr. Hwang is a stem-
cell researcher in South Korea who published 
two papers in Science in 2004 and 2005 with 
many authors — mostly his own group at Seoul 
National University, but there were also Ameri-
can colleagues. The first paper showed that 
it is possible to produce a pluripotent human 
embryonic stem cell by transferring the nucleus 
from a somatic cell taken from an adult into an 
unfertilized oocyte.4 Aft er somatic-cell nuclear 
transfer, the cell was cultured to the blastocyst 
stage, and embryonic stem cells were harvested. 
Th e genotype of these embryonic stem cells was 
said to be identical to that of the donor nucleus. 
Of the 242 oocytes used, only one embryonic 
stem cell line resulted. But in the next article, 
the results were much better; 11 embryonic 
stem cell lines were said to have been produced 
from 20 oocytes.5 Here the interesting point was 
that the cell lines represented the genotype of 
patients with juvenile diabetes mellitus, spinal 
cord injury, or other disorders.
So let us ask: was this a big deal? It certainly 
represented a technologic advance; it had not 
been possible to produce these embryonic stem 
cells with this effi  ciency previously. However, 
as sourpuss reviewers oft en say of such stud-
ies, these were merely extensions to humans of 
studies that had been done in animals. Simply 
because anything done in humans is inherently 
more exciting, this represented a news item; 
whether it really warranted placement on the 
front pages of major newspapers must be left  
to the papers’ editors. I have to emphasize that 
there was no scientifi c news here, no change in 
theory, no advance in knowledge; the method 
was described but did not seem to be diff erent 
from that applied in sheep, mice, cows, and so 
on. So was it the pH of their solution; the mag-
nesium concentration; the serum they used? 
One day we would fi nd out, but whatever it was, 
it represented some small advance. We do need 
effi  cient methods to produce embryonic stem 
cell lines, but this is technology, not science. So 
why was it published in such a high-profi le jour-
nal? Well, it was newsworthy; that is the only 
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answer that I could fi nd on close reading of that rather unread-
able article even at the time of its original publication.
Th en the house of cards started to totter. First it appeared 
that the donors of the oocytes were colleagues, postdocs, and 
technicians of the research team. Th is raised an initial fl urry of 
exponential responses, based on orientalist ideas of how the 
East conducts research, with veiled cultural-supremacist views 
of how ‘they’ cannot confront authority whereas ‘we’ coura-
geously do — conveniently forgetting, of course, that these ethi-
cal lapses were uncovered by the Koreans themselves. Hwang’s 
attempt to cover up the sources of the cells raised even more 
suspicions in Korea and led to the investigation by his univer-
sity that eventually showed that the majority of his results were 
essentially manufactured.
So what should our response be? Is this a blemish on science? 
On stem-cell research? On oriental ethics? All of these view-
points have been discussed in the lay and even the scientifi c 
press, but my answer is: None of the above! A rogue scientist 
wanted to be famous, and he played on the Korean govern-
ment’s desire to be seen as a supporter of cutting-edge science 
(imagine! how any government could be so foolish). But it is not 
easy to get away with fraud in science. Th e reason is that even 
rogues and crooks have motives, and their motive is their need 
for fame and fortune, just like the rest of us! Let us look at the 
reward system of science. Scientists become famous (and rich, 
one hopes) because they make a signifi cant scientifi c or techno-
logic advance. Th e coin of the realm is the respect of your peers, 
which ranges from the minor (having your papers cited) to the 
middling (getting promoted and receiving grants) to the major 
(receiving prizes). If you cheat on something important, every-
body and their brother is going to try to beat you at extending 
the work to the next step, because yesterday’s breakthrough is 
today’s boring news in our never-ending search for the new. 
Th e next step oft en entails repeating some of the original stud-
ies, which is where the non-reproducibility problems begin to 
appear. If the work is trivial and nobody cares about the results, 
you can cheat to your heart’s content, because nobody is going 
to bother repeating your studies. But trivial work is not going 
to be rewarded.
What is the role of journals and the peer review system in 
ensuring the elimination of fraud? First let me report that many 
journals have been taken aback by this debacle and have started 
to investigate their peer review process. I must say I am less 
worried. We have to start from the understanding that science 
is a human activity, subject to all the pathologic behavior that 
accompanies such activity. Journals begin and end with trust, 
implicit and explicit, that when authors say they did something, 
they actually did it. Journals do not have the power or resources 
to police scientists, nor, for that matter, do their universities, 
the funding agencies, or the government. Reviewers, a skeptical 
breed by nature, sometimes fi nd problems in papers that look 
suspicious. Oft en their suspicions are easy to allay; the prob-
lems, more oft en than not, were innocent errors of labeling. 
Occasionally an eagle-eyed reviewer fi nds that two gels in the 
same paper look suspiciously alike in terms of the presence of 
various noisy signals and alerts the editor. Th ings have changed 
with the introduction of Photoshop, with which it is possible 
to essentially construct complete but fraudulent data with an 
ease never known before. Th ere are computer whizzes who can 
decipher these Photoshop documents and tell the way they were 
put together. Th is was done for Hwang’s second paper. At this 
point the duty of the editor is clear: if we cannot resolve the 
matter readily, we must alert the Offi  ce of Research Integrity at 
the National Institutes of Health, which then deals with it. But 
this is a rare event. We cannot investigate every paper submit-
ted to the journal; how would we know, for instance, that when 
Jon Sudbø, with 13 coauthors, submitted a paper purporting to 
have used a Norwegian Institute of Public Health database to 
study the role of nonsteroidal anti-infl ammatory drugs in oral 
cancer6, the data were made up? Nobody would have been the 
wiser had the director of epidemiology at the Institute not been 
catching up on her reading during the Christmas holidays and 
come across this paper. As she is responsible for allowing the 
use of these databases, imagine her surprise at fi nding a study 
that she had not approved. In the famous words of Mary McCa-
rthy, “every word…[was] a lie, including ‘and’ and ‘the.’”
Th e function of editors and reviewers is to assure the readers 
that the conclusion drawn in a paper follows from the studies 
done. Moral education and surveillance, one the function of 
parents, the other of the police, are not part of our job descrip-
tion. One could suggest, as the editor of Nature did recently 
(only to dismiss the idea immediately), that we ask for an 
independent verifi cation of the central result of a paper, but 
clearly that would simply put the brake on all submissions to 
that journal, let alone being an insult to the vast majority of sci-
entists. Science is a self-correcting enterprise in which authors, 
reviewers, editors, journalists, and readers, especially the sci-
entifi c readership, play a critical role. Science, unlike politics, 
is evidence-based (we await impatiently the development of 
evidence-based politics). So the lesson of the Hwang debacle 
is that, in science, it is possible to fool people some of the time, 
but one cannot fool most scientists for a long time.
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